Draft genome sequence of a prodigiosin-hyperproducing Serratia marcescens strain isolated from Cairo, Egypt

Nora M Elkenawy; Noha H Youssef; Ramy K Aziz; Magdy A Amin; Aymen S Yassin

doi:10.1093/g3journal/jkab284

Draft genome sequence of a prodigiosin-hyperproducing Serratia marcescens strain isolated from Cairo, Egypt

G3 (Bethesda). 2021 Sep 27;11(10):jkab284. doi: 10.1093/g3journal/jkab284.

Authors

Nora M Elkenawy¹, Noha H Youssef², Ramy K Aziz^{3

4

5}, Magdy A Amin^{2

3}, Aymen S Yassin^{3

4}

Affiliations

¹ Drug Radiation Research Department, National Center for Radiation Research &Technology, 11787 Cairo, Egypt.
² Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078-5061, USA.
³ Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, 11562 Cairo, Egypt.
⁴ The Center for Genome and Microbiome Research, Cairo University, 11562 Cairo, Egypt.
⁵ Microbiology and Immunology Research Program, Children's Cancer Hospital Egypt 57357, 11617 Cairo, Egypt.

Abstract

Serratia marcescens is a Gram-negative bacterium with both environmental and host-associated strains. Pigmentation is reportedly inversely correlated with infection frequency, and prodigiosin is one of Serratia pigments that has medical and industrial applications. Here, we report the draft genome sequence of prodigiosin-hyperproducing Serratia marcescens strain N2, isolated from Cairo, Egypt. The sequence is assembled into 142 contigs, with a combined size of 5,570,793 bp. The assembled genome carries typical S. marcescens genes, with potential prodigiosin-biosynthesizing genes detected.

Keywords: Serratia marcescens; bioinformatics; genome annotation; genome assembly; prodigiosin.

MeSH terms

Egypt
Pigmentation
Prodigiosin*
Serratia marcescens* / genetics

Substances

Prodigiosin